IFNlambda Therapy Prevents Severe Gastrointestinal Graft-versus-Host Disease. Henden AS, Koyama M, Robb RJ, Forero A, et al. Blood 2021 May 5. pii: 475908. doi: 10.1182/blood.2020006375.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Henden AS, Koyama M, Robb RJ, Forero A, et al. IFNlambda Therapy Prevents Severe Gastrointestinal Graft-versus-Host Disease. Blood 2021 May 5. pii: 475908. doi: 10.1182/blood.2020006375.
PMID: 33951730